Zoetis Inc. Class A

Symbol: ZTS     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
0.58%
Current Price
$113.92
Info     Dividend Rate History     Dividend Yield History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-10 23:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
1,455,000,000
1,455,000,000
518,000,000
937,000,000
509,000,000
428,000,000
312,000,000
4,379,000,000
10,883,000,000
8,566,000,000
2,317,000,000
1,728,000,000
-
1,793,000,000
-
123,000,000
389,000,000
 
102,000,000

Financials 2018

Update: 2019-06-10 23:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
1,564,000,000
1,564,000,000
544,000,000
1,020,000,000
584,000,000
436,000,000
345,000,000
4,399,000,000
10,777,000,000
8,592,000,000
2,185,000,000
1,602,000,000
9,000,000
1,701,000,000
6,452,000,000
313,000,000
584,000,000
 
125,000,000

Q 3

2018-09-30
1,480,000,000
1,480,000,000
473,000,000
1,007,000,000
507,000,000
500,000,000
347,000,000
4,076,000,000
10,459,000,000
8,341,000,000
2,118,000,000
1,286,000,000
-
1,391,000,000
-
-251,000,000
550,000,000
 
108,000,000

Q 2

2018-06-30
1,415,000,000
1,415,000,000
447,000,000
968,000,000
484,000,000
484,000,000
384,000,000
4,239,000,000
8,603,000,000
6,621,000,000
1,970,000,000
1,558,000,000
-
1,558,000,000
-
-80,000,000
267,000,000
 
102,000,000

Q 1

2018-03-31
1,366,000,000
1,366,000,000
447,000,000
919,000,000
458,000,000
461,000,000
352,000,000
4,267,000,000
8,690,000,000
6,715,000,000
1,960,000,000
1,654,000,000
-
1,654,000,000
-
82,000,000
389,000,000
 
97,000,000

Financials 2017

Update: 2019-06-10 23:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
1,460,000,000
1,460,000,000
457,000,000
1,003,000,000
494,000,000
509,000,000
81,000,000
4,217,000,000
8,586,000,000
6,800,000,000
1,770,000,000
1,564,000,000
-
1,564,000,000
-
-413,000,000
608,000,000
 
110,000,000